The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 1,821,999 | 247,891 | SH | SOLE | 247,891 | 0 | 0 | |||
AMGEN INC | COM | 031162100 | 5,252,800 | 20,000 | SH | Put | SOLE | 20,000 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 7,439,630 | 240,143 | SH | SOLE | 240,143 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 1,894,150 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | |||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 8,670,864 | 70,997 | SH | SOLE | 70,997 | 0 | 0 | |||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,068,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 7,035,257 | 472,482 | SH | SOLE | 472,482 | 0 | 0 | |||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 4,715,633 | 573,678 | SH | SOLE | 573,678 | 0 | 0 | |||
BIOATLA INC | COM | 09077B104 | 1,237,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,279,200 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 3,895,290 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 3,410,048 | 7,500,000 | PRN | SOLE | 7,500,000 | 0 | 0 | |||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 12,591,250 | 175,000 | SH | Put | SOLE | 175,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 4,902,700 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 1,427,017 | 460,328 | SH | SOLE | 460,328 | 0 | 0 | |||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 6,781,100 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | |||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 21,432,517 | 818,035 | SH | SOLE | 818,035 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 2,231,820 | 193,064 | SH | SOLE | 193,064 | 0 | 0 | |||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 583,653 | 883,654 | SH | SOLE | 883,654 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 7,169,939 | 1,143,531 | SH | SOLE | 1,143,531 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 4,013,878 | 87,601 | SH | SOLE | 87,601 | 0 | 0 | |||
DYNE THERAPEUTICS INC | COM | 26818M108 | 1,068,250 | 92,170 | SH | SOLE | 92,170 | 0 | 0 | |||
ESPERION THERAPEUTICS INC NE | NOTE 4.000%11/1 | 29664WAB1 | 1,363,928 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | |||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 12,523,854 | 190,767 | SH | SOLE | 190,767 | 0 | 0 | |||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 701,743 | 109,991 | SH | SOLE | 109,991 | 0 | 0 | |||
GERON CORP | COM | 374163103 | 2,556,730 | 1,056,500 | SH | Put | SOLE | 1,056,500 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 2,025,540 | 837,000 | SH | Call | SOLE | 837,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 5,121,000 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | |||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 469,882 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | |||
INARI MED INC | COM | 45332Y109 | 5,720,400 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
INOZYME PHARMA INC | COM | 45790W108 | 525,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,396,250 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,272,854 | 188,292 | SH | SOLE | 188,292 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 2,248,298 | 661,264 | SH | SOLE | 661,264 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 3,335,150 | 268,747 | SH | SOLE | 268,747 | 0 | 0 | |||
LANTHEUS HLDGS INC | COM | 516544103 | 3,089,705 | 60,630 | SH | SOLE | 60,630 | 0 | 0 | |||
LIANBIO | SPONSORED ADS | 53000N108 | 1,066,000 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 20,317,500 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 2,933 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | |||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 396,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 780,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
MODERNA INC | COM | 60770K107 | 5,388,600 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 7,514,637 | 280,921 | SH | SOLE | 280,921 | 0 | 0 | |||
NOVAVAX INC | COM NEW | 670002401 | 2,056,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | ||
NOVOCURE LTD | ORD SHS | G6674U108 | 1,833,750 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 878,400 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
NUVATION BIO INC | COM CL A | 67080N101 | 480,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 2,210,459 | 303,218 | SH | SOLE | 303,218 | 0 | 0 | |||
PRECIGEN INC | NOTE 3.500% 7/0 | 46122TAA0 | 1,487,981 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | |||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 8,250,000 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 5,051,311 | 258,115 | SH | SOLE | 258,115 | 0 | 0 | |||
SCILEX HOLDING CO | *W EXP 11/10/202 | 80880W114 | 3,419 | 18,099 | SH | SOLE | 18,099 | 0 | 0 | |||
SCILEX HOLDING CO | COM | 80880W106 | 1,847 | 463 | SH | SOLE | 463 | 0 | 0 | |||
SEAGEN INC | COM | 81181C104 | 642,550 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 2,545,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 2,877,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 7,890,028 | 240,623 | SH | SOLE | 240,623 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADR | 925050106 | 8,165,573 | 312,498 | SH | SOLE | 312,498 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 2,743,650 | 105,000 | SH | Call | SOLE | 105,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 3,290,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 2,350,000 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 1,522,626 | 1,492,771 | SH | SOLE | 1,492,771 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,971,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 |